论文信息 - Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses. - 字舞流文

Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses.

L. Boulet | P. O'Byrne | D. Cockcroft | K. Killian | R. Watson | G. Gauvreau | B. Dahlén | M. Laviolette | R. Leigh | J. Arm | A. Drollmann | J. FitzGerald | S. Maahs | B. Davis | P. Lowe | C. Carlsten | I. Mayers | J. Milot | Miranda Bowen | L. Hui | A. Skerjanec | Nikolaos Lazarinis | V. Swystun | Ann-Sofie Lantz | Karin Meiser | N. Lazarinis | Ann‐Sofie Lantz | Paul M. O'Byrne | Jonathan P. Arm | J. FitzGerald | Philip J. Lowe | Kieran J. Killian